Antiangiogenic Activity of Tumor Necrosis Factor-α Production Regulators Derived from Thalidomide
Recently, we developed novel tumor necrosis factor (TNF)-α production regulators with a phthalimide skeleton derived fromthalidomide. We show here that some of these compounds are more potent inhibitors than thalidomide of angiogenesis induced by basic fibroblast growth factor in a murine angiogenes...
Gespeichert in:
Veröffentlicht in: | Biological & pharmaceutical bulletin 1999/02/15, Vol.22(2), pp.224-226 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 226 |
---|---|
container_issue | 2 |
container_start_page | 224 |
container_title | Biological & pharmaceutical bulletin |
container_volume | 22 |
creator | SHIMAZAWA, Rumiko MIYACHI, Hiroyuki TAKAYAMA, Hisae KURODA, Kensei KATO, Fuminori KATO, Masanari HASHIMOTO, Yuichi |
description | Recently, we developed novel tumor necrosis factor (TNF)-α production regulators with a phthalimide skeleton derived fromthalidomide. We show here that some of these compounds are more potent inhibitors than thalidomide of angiogenesis induced by basic fibroblast growth factor in a murine angiogenesis assay. |
doi_str_mv | 10.1248/bpb.22.224 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69621997</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69621997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c599t-8767fe10b011417d4a700e0898ea5fa6a204d165d119b7de42c60ae53ec23fb53</originalsourceid><addsrcrecordid>eNpN0M1q3DAQAGBREppNmksfoOhQeig4lWTZso7LpkkDISllczZjabxRsK2tZC_ksfIifaZqs5sfGCSh-ZiRhpDPnJ1xIasfzbo5EyKF_EBmPJcqKwQvDsiMaV5lJS-qI3Ic4wNjTDGRfyRHPJ2UlHpGmvkwOhhWzq9wcIbOzeg2bnykvqXLqfeB3qAJPrpIL8CMPmT_nujv4O2UoB_oH1xNHaT7SM8xuA1a2gbf0-U9dM763ln8RA5b6CKe7vcTcnfxc7n4lV3fXl4t5teZKbQes0qVqkXOGsa55MpKUIwhq3SFULRQgmDS8rKwnOtGWZTClAywyNGIvG2K_IR829VdB_93wjjWvYsGuw4G9FOsS10KrrVK8PsObj8WA7b1OrgewmPNWb2daJ0mWguRQib8ZV91anq07-huhAl83QOIBro2wGBcfHMql0KIxBY79hBHWOFrHsLoTIfblulx-XPbl0W-Zs09hBqH_D9taJcm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69621997</pqid></control><display><type>article</type><title>Antiangiogenic Activity of Tumor Necrosis Factor-α Production Regulators Derived from Thalidomide</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>SHIMAZAWA, Rumiko ; MIYACHI, Hiroyuki ; TAKAYAMA, Hisae ; KURODA, Kensei ; KATO, Fuminori ; KATO, Masanari ; HASHIMOTO, Yuichi</creator><creatorcontrib>SHIMAZAWA, Rumiko ; MIYACHI, Hiroyuki ; TAKAYAMA, Hisae ; KURODA, Kensei ; KATO, Fuminori ; KATO, Masanari ; HASHIMOTO, Yuichi</creatorcontrib><description>Recently, we developed novel tumor necrosis factor (TNF)-α production regulators with a phthalimide skeleton derived fromthalidomide. We show here that some of these compounds are more potent inhibitors than thalidomide of angiogenesis induced by basic fibroblast growth factor in a murine angiogenesis assay.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.22.224</identifier><identifier>PMID: 10077449</identifier><language>eng</language><publisher>Tokyo: The Pharmaceutical Society of Japan</publisher><subject>AIDS/HIV ; Animals ; antiangiogenesis ; Antineoplastic agents ; Biological and medical sciences ; Chemotherapy ; Fibroblast Growth Factor 2 - pharmacology ; Humans ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Neovascularization, Pathologic - prevention & control ; Pharmacology. Drug treatments ; phthalimide ; Stereoisomerism ; thalidomide ; Thalidomide - analogs & derivatives ; Thalidomide - chemistry ; Thalidomide - pharmacology ; Tumor Cells, Cultured ; Tumor Necrosis Factor-alpha - biosynthesis ; tumor necrosis factor-α</subject><ispartof>Biological and Pharmaceutical Bulletin, 1999/02/15, Vol.22(2), pp.224-226</ispartof><rights>The Pharmaceutical Society of Japan</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c599t-8767fe10b011417d4a700e0898ea5fa6a204d165d119b7de42c60ae53ec23fb53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27902,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1734222$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10077449$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SHIMAZAWA, Rumiko</creatorcontrib><creatorcontrib>MIYACHI, Hiroyuki</creatorcontrib><creatorcontrib>TAKAYAMA, Hisae</creatorcontrib><creatorcontrib>KURODA, Kensei</creatorcontrib><creatorcontrib>KATO, Fuminori</creatorcontrib><creatorcontrib>KATO, Masanari</creatorcontrib><creatorcontrib>HASHIMOTO, Yuichi</creatorcontrib><title>Antiangiogenic Activity of Tumor Necrosis Factor-α Production Regulators Derived from Thalidomide</title><title>Biological & pharmaceutical bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>Recently, we developed novel tumor necrosis factor (TNF)-α production regulators with a phthalimide skeleton derived fromthalidomide. We show here that some of these compounds are more potent inhibitors than thalidomide of angiogenesis induced by basic fibroblast growth factor in a murine angiogenesis assay.</description><subject>AIDS/HIV</subject><subject>Animals</subject><subject>antiangiogenesis</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Fibroblast Growth Factor 2 - pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neovascularization, Pathologic - prevention & control</subject><subject>Pharmacology. Drug treatments</subject><subject>phthalimide</subject><subject>Stereoisomerism</subject><subject>thalidomide</subject><subject>Thalidomide - analogs & derivatives</subject><subject>Thalidomide - chemistry</subject><subject>Thalidomide - pharmacology</subject><subject>Tumor Cells, Cultured</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>tumor necrosis factor-α</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpN0M1q3DAQAGBREppNmksfoOhQeig4lWTZso7LpkkDISllczZjabxRsK2tZC_ksfIifaZqs5sfGCSh-ZiRhpDPnJ1xIasfzbo5EyKF_EBmPJcqKwQvDsiMaV5lJS-qI3Ic4wNjTDGRfyRHPJ2UlHpGmvkwOhhWzq9wcIbOzeg2bnykvqXLqfeB3qAJPrpIL8CMPmT_nujv4O2UoB_oH1xNHaT7SM8xuA1a2gbf0-U9dM763ln8RA5b6CKe7vcTcnfxc7n4lV3fXl4t5teZKbQes0qVqkXOGsa55MpKUIwhq3SFULRQgmDS8rKwnOtGWZTClAywyNGIvG2K_IR829VdB_93wjjWvYsGuw4G9FOsS10KrrVK8PsObj8WA7b1OrgewmPNWb2daJ0mWguRQib8ZV91anq07-huhAl83QOIBro2wGBcfHMql0KIxBY79hBHWOFrHsLoTIfblulx-XPbl0W-Zs09hBqH_D9taJcm</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>SHIMAZAWA, Rumiko</creator><creator>MIYACHI, Hiroyuki</creator><creator>TAKAYAMA, Hisae</creator><creator>KURODA, Kensei</creator><creator>KATO, Fuminori</creator><creator>KATO, Masanari</creator><creator>HASHIMOTO, Yuichi</creator><general>The Pharmaceutical Society of Japan</general><general>Maruzen</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1999</creationdate><title>Antiangiogenic Activity of Tumor Necrosis Factor-α Production Regulators Derived from Thalidomide</title><author>SHIMAZAWA, Rumiko ; MIYACHI, Hiroyuki ; TAKAYAMA, Hisae ; KURODA, Kensei ; KATO, Fuminori ; KATO, Masanari ; HASHIMOTO, Yuichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c599t-8767fe10b011417d4a700e0898ea5fa6a204d165d119b7de42c60ae53ec23fb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>AIDS/HIV</topic><topic>Animals</topic><topic>antiangiogenesis</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Fibroblast Growth Factor 2 - pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neovascularization, Pathologic - prevention & control</topic><topic>Pharmacology. Drug treatments</topic><topic>phthalimide</topic><topic>Stereoisomerism</topic><topic>thalidomide</topic><topic>Thalidomide - analogs & derivatives</topic><topic>Thalidomide - chemistry</topic><topic>Thalidomide - pharmacology</topic><topic>Tumor Cells, Cultured</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SHIMAZAWA, Rumiko</creatorcontrib><creatorcontrib>MIYACHI, Hiroyuki</creatorcontrib><creatorcontrib>TAKAYAMA, Hisae</creatorcontrib><creatorcontrib>KURODA, Kensei</creatorcontrib><creatorcontrib>KATO, Fuminori</creatorcontrib><creatorcontrib>KATO, Masanari</creatorcontrib><creatorcontrib>HASHIMOTO, Yuichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biological & pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SHIMAZAWA, Rumiko</au><au>MIYACHI, Hiroyuki</au><au>TAKAYAMA, Hisae</au><au>KURODA, Kensei</au><au>KATO, Fuminori</au><au>KATO, Masanari</au><au>HASHIMOTO, Yuichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antiangiogenic Activity of Tumor Necrosis Factor-α Production Regulators Derived from Thalidomide</atitle><jtitle>Biological & pharmaceutical bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>1999</date><risdate>1999</risdate><volume>22</volume><issue>2</issue><spage>224</spage><epage>226</epage><pages>224-226</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>Recently, we developed novel tumor necrosis factor (TNF)-α production regulators with a phthalimide skeleton derived fromthalidomide. We show here that some of these compounds are more potent inhibitors than thalidomide of angiogenesis induced by basic fibroblast growth factor in a murine angiogenesis assay.</abstract><cop>Tokyo</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>10077449</pmid><doi>10.1248/bpb.22.224</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-6158 |
ispartof | Biological and Pharmaceutical Bulletin, 1999/02/15, Vol.22(2), pp.224-226 |
issn | 0918-6158 1347-5215 |
language | eng |
recordid | cdi_proquest_miscellaneous_69621997 |
source | J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry |
subjects | AIDS/HIV Animals antiangiogenesis Antineoplastic agents Biological and medical sciences Chemotherapy Fibroblast Growth Factor 2 - pharmacology Humans Medical sciences Mice Mice, Inbred BALB C Neovascularization, Pathologic - prevention & control Pharmacology. Drug treatments phthalimide Stereoisomerism thalidomide Thalidomide - analogs & derivatives Thalidomide - chemistry Thalidomide - pharmacology Tumor Cells, Cultured Tumor Necrosis Factor-alpha - biosynthesis tumor necrosis factor-α |
title | Antiangiogenic Activity of Tumor Necrosis Factor-α Production Regulators Derived from Thalidomide |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T11%3A35%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antiangiogenic%20Activity%20of%20Tumor%20Necrosis%20Factor-%CE%B1%20Production%20Regulators%20Derived%20from%20Thalidomide&rft.jtitle=Biological%20&%20pharmaceutical%20bulletin&rft.au=SHIMAZAWA,%20Rumiko&rft.date=1999&rft.volume=22&rft.issue=2&rft.spage=224&rft.epage=226&rft.pages=224-226&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.22.224&rft_dat=%3Cproquest_cross%3E69621997%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69621997&rft_id=info:pmid/10077449&rfr_iscdi=true |